Filtered By:
Source: Frontiers in Oncology
Management: Employment
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Discovery and Pharmacological Evaluation of STEAP4 as a Novel Target for HER2 Overexpressing Breast Cancer
In conclusion, STEAP4 may represent a novel BC related biomarker and a potential pharmacological target for the treatment of HER2 overexpressing BC.
Source: Frontiers in Oncology - March 26, 2021 Category: Cancer & Oncology Source Type: research
